Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enzastaurin in recurrent ovarian or primary peritoneal cancer
NCT00407758Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- Nov 2006
- Primary completion
- Aug 2016
- Countries
- 1
01
Overview
A Phase 2 trial of enzastaurin in ovarian epithelial carcinoma, primary peritoneal carcinoma (PPC), sponsored by GOG Foundation. Started Nov 2006; status: completed.
02
Drugs
enzastaurin
03
Conditions
ovarian epithelial carcinomaprimary peritoneal carcinoma (PPC)
Beyond the preview
Go deeper on NCT00407758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00407758.